Showing results (541-550 of 6,290) with videos related to
Sort By:
Pageof 629
Diabetes, Obesity & Metabolism|January 12, 2005
Islet adaptation to insulin resistance: mechanisms and implications for interventionB Ahrén, G PaciniDiabetes, Obesity & Metabolism|January 12, 2005
Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetesT Haak, A Tiengo, E Draeger, et al.Diabetes, Obesity & Metabolism|January 12, 2005
Efficacy and safety of ezetimibe co-administered with simvastatin in thiazolidinedione-treated type 2 diabetic patientsL M Gaudiani, A Lewin, L Meneghini, et al.Diabetes, Obesity & Metabolism|February 18, 2005
Comparison of pioglitazone with other antidiabetic drugs for associated incidence of liver failure: no evidence of increased risk of liver failure with pioglitazoneR Rajagopalan, S Iyer, A PerezDiabetes, Obesity & Metabolism|August 2, 2008
Glycaemic separation and risk factor control in the Veterans Affairs Diabetes Trial: an interim reportC Abraira, W C Duckworth, T Moritz, et al.Diabetes, Obesity & Metabolism|August 2, 2008
Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT)A M Sharma, I D Caterson, W Coutinho, et al.Diabetes, Obesity & Metabolism|June 23, 2017
Favourable changes in mortality in people with diabetes: US NHANES 1999-2010Tetsuro Tsujimoto, Hiroshi Kajio, Takehiro SugiyamaDiabetes, Obesity & Metabolism|February 16, 2010
A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention studyA Elhayany, A Lustman, R Abel, et al.Diabetes, Obesity & Metabolism|February 16, 2010
Open-label study to assess the safety and pharmacodynamics of five oral insulin formulations in healthy subjectsR Eldor, M Kidron, E ArbitDiabetes, Obesity & Metabolism|February 16, 2010
Combination treatment with alogliptin and voglibose increases active GLP-1 circulation, prevents the development of diabetes and preserves pancreatic beta-cells in prediabetic db/db miceY Moritoh, K Takeuchi, M HazamaPageof 629